Literature DB >> 29807938

Herpes zoster ophthalmicus.

Paul R Freund1, Sylvia H Chen2.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 29807938      PMCID: PMC5973887          DOI: 10.1503/cmaj.180063

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Prognostic value of Hutchinson's sign for ocular involvement in herpes zoster ophthalmicus.

Authors:  Florian Butsch; Dania Greger; Christina Butsch; Esther von Stebut
Journal:  J Dtsch Dermatol Ges       Date:  2017-04-18       Impact factor: 5.584

Review 2.  Management and Prevention of Herpes Zoster Ocular Disease.

Authors:  Elisabeth J Cohen
Journal:  Cornea       Date:  2015-10       Impact factor: 2.651

3.  Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.

Authors:  Himal Lal; Anthony L Cunningham; Olivier Godeaux; Roman Chlibek; Javier Diez-Domingo; Shinn-Jang Hwang; Myron J Levin; Janet E McElhaney; Airi Poder; Joan Puig-Barberà; Timo Vesikari; Daisuke Watanabe; Lily Weckx; Toufik Zahaf; Thomas C Heineman
Journal:  N Engl J Med       Date:  2015-04-28       Impact factor: 91.245

4.  Treatment of herpes zoster ophthalmicus: a systematic review and Canadian cost-comparison.

Authors:  Stacy Fan; Daniel Stojanovic; Monali S Malvankar-Mehta; Cindy Hutnik
Journal:  Can J Ophthalmol       Date:  2017-10-10       Impact factor: 1.882

Review 5.  Post-herpetic neuralgia - a review of current management and future directions.

Authors:  John Schutzer-Weissmann; Paul Farquhar-Smith
Journal:  Expert Opin Pharmacother       Date:  2017-10-26       Impact factor: 3.889

  5 in total
  1 in total

1.  Supraorbital Nerve Radiofrequency for Severe Neuralgia Caused by Herpes Zoster Ophthalmicus.

Authors:  Huan Zhang; Huadong Ni; Songlei Liu; Keyue Xie
Journal:  Pain Res Manag       Date:  2020-09-25       Impact factor: 3.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.